GoPro insider notice: 150,043 shares planned for sale via Morgan Stanley
Rhea-AI Filing Summary
Form 144 notice from an insider of GoPro, Inc. (GPRO) proposes the sale of 150,043 common shares via Morgan Stanley Smith Barney. The filing lists an aggregate market value of $186,548.46 and shows approximately 158,183,095 shares outstanding. The proposed sale date is 08/20/2025 on NASDAQ. The securities to be sold were acquired in multiple grant events from the issuer, including performance shares and restricted stock dated between 05/15/2024 and 08/15/2025, with the largest single acquisition line showing 70,111 restricted shares dated 02/15/2025. The filer reports no securities sold by the account in the past three months. The remarks section includes the standard representation about absence of undisclosed material adverse information; no specific plan adoption date or signature block details are provided in the text.
Positive
- Broker and exchange disclosed: sale will be handled by Morgan Stanley Smith Barney on NASDAQ, providing execution transparency
- Acquisitions documented: detailed acquisition dates and types (performance shares, restricted stock) are listed, supporting traceability of origin
Negative
- Key filing elements missing: the provided content does not include signer identification, explicit date of notice, or a stated plan-adoption date for any 10b5-1 plan
- Relatively small disclosure value: the aggregate market value ($186,548.46) is modest relative to the issuer's outstanding shares, limiting material impact
Insights
TL;DR: Insider plans to sell 150,043 GPRO shares (~$186.5k) acquired largely via recent equity grants; no recent sales reported.
The filing documents a proposed sale executed through Morgan Stanley Smith Barney with an approximate trade date of 08/20/2025. The shares originate from multiple equity award events (performance shares and restricted stock) spanning 05/15/2024 to 08/15/2025, indicating the position arises from compensation rather than open-market purchases. The absence of reported sales in the prior three months suggests this is a new disposition activity for the account. The dollar value relative to total outstanding shares is small based on the reported outstanding share count. The form does not include signature details, plan-adoption dates, or any narrative context beyond the standard Rule 144 attestations.
TL;DR: Transaction appears routine: sale of compensation-originated shares via broker; disclosure aligns with Rule 144 requirements.
The schedule of acquisitions lists multiple issuer-originated equity grants and restricted stock deliveries, consistent with executive or employee compensation vesting. The notice includes the broker name and planned execution venue (NASDAQ). There is no indication of aggregated sales in the prior three months and no additional governance or compliance issues disclosed in the text. Missing elements include signer identification and explicit plan adoption date if relying on Rule 10b5-1; the form shows the standard attestation but lacks those specifics in the provided content.